Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Ra Ri Cha 2 Articles
Primary Gastric Small Cell Carcinoma (Presenting as Linitis Plastica) Diagnosed Using Endoscopic Ultrasound-Guided Biopsy: A Case Report
Ra Ri Cha, Jin Kyu Cho, Wan Soo Kim, Jin Joo Kim, Jae Min Lee, Sang Soo Lee, Hyun Jin Kim
Clin Endosc 2019;52(3):278-282.   Published online October 5, 2018
DOI: https://doi.org/10.5946/ce.2018.114
AbstractAbstract PDFPubReaderePub
Small cell carcinomas are the most aggressive, highly malignant neuroendocrine tumors; among these, gastric small cell carcinoma (GSCC) is extremely rare. Here we report a case of a patient with primary GSCC, presenting as linitis plastic, who was diagnosed using endoscopic ultrasound (EUS)-guided biopsy. With undiagnosed linitis plastica, an 80-year-old woman was referred to our institution. Abdominal computed tomography revealed irregular wall thickening extending from the gastric body to the antrum. Endoscopy suspected to have Borrmann type IV advanced gastric cancer. EUS of the stomach showed diffuse submucosal thickening of the gastric wall, mainly the antrum. EUS-guided bite-on-bite biopsy confirmed the diagnosis of GSCC. In general, GSCC is difficult to diagnose and careful examination is necessary to determine the therapeutic strategy; however, EUS is particularly helpful in the differential diagnosis of a lesion presenting as linitis plastica.

Citations

Citations to this article as recorded by  
  • An online tool for survival prediction of extrapulmonary small cell carcinoma with random forest
    Xin Zhang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Gastric linitis plastica due to signet-ring cell carcinoma with Krukenberg tumors diagnosed by endoscopic ultrasound-guided fine-needle aspiration
    Takeshi Okamoto, Hidekazu Suzuki, Katsuyuki Fukuda
    Clinical Journal of Gastroenterology.2021; 14(4): 994.     CrossRef
  • A case report of advanced gastric small cell carcinoma with neoadjuvant chemotherapy followed by radical total gastrectomy
    Bing Wang, Nanlin Jiao, Lianghui Shi
    Asian Journal of Surgery.2020; 43(12): 1205.     CrossRef
  • 8,300 View
  • 162 Download
  • 3 Web of Science
  • 3 Crossref
Close layer
Fecal microbiota transplantation: present and future
Ra Ri Cha, Irene Sonu
Received October 8, 2024  Accepted December 15, 2024  Published online March 25, 2025  
DOI: https://doi.org/10.5946/ce.2024.270    [Epub ahead of print]
AbstractAbstract PDFPubReaderePub
Fecal microbiota transplantation (FMT) involves transplanting fecal matter from healthy donors into patients with gut dysbiosis to restore microbial balance. It has been proven to be highly effective in treating recurrent Clostridioides difficile infection (CDI), and United States Food and Drug Administration-approved microbiome-based therapies, such as REBYOTA (fecal microbiota live-jslm) and VOWST (fecal microbiota spores live-brpk), offer promising treatment options. Although FMT is widely used to treat recurrent CDI, its use in gastrointestinal and metabolic diseases remains limited. Future research directions include optimizing donor selection, understanding microbial mechanisms, and exploring the potential of FMT for treating other diseases. Ongoing research not only aims to broaden its indications but also improves its safety and efficacy. Emerging therapies such as VE303 (Vedanta) are being studied to refine treatment approaches and expand the use of microbiota-based therapies. Further studies are needed to standardize guidelines, improve patient outcomes, and better define the role of FMT in the treatment of diseases beyond recurrent CDI.
  • 2,185 View
  • 98 Download
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP